Chugai Pharmaceutical Co., Ltd Stock price

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange 01:00:00 2024-02-26 am EST 5-day change 1st Jan Change
6,008 JPY +6.37% Intraday chart for Chugai Pharmaceutical Co., Ltd +1.76% +12.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 1,111B 7.38B Sales 2024 * 1,104B 7.33B Capitalization 9,293B 61.69B
Net income 2023 325B 2.16B Net income 2024 * 346B 2.29B EV / Sales 2023 7.24 x
Net cash position 2023 739B 4.91B Net cash position 2024 * 756B 5.02B EV / Sales 2024 * 7.73 x
P/E ratio 2023
27 x
P/E ratio 2024 *
26.9 x
Employees 7,771
Yield 2023
1.5%
Yield 2024 *
1.47%
Free-Float 38.08%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Chugai Pharmaceutical Co., Ltd

1 day+6.37%
1 week+3.96%
Current month+12.36%
1 month+10.93%
3 months+20.16%
6 months+36.14%
Current year+12.47%
More quotes
1 week
5 288.00
Extreme 5288
6 043.00
1 month
5 043.00
Extreme 5043
6 043.00
Current year
5 043.00
Extreme 5043
6 043.00
1 year
3 203.00
Extreme 3203
6 043.00
3 years
3 191.00
Extreme 3191
6 043.00
5 years
2 240.00
Extreme 2240
6 435.00
10 years
786.33
Extreme 786.3333
6 435.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 87-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 79 15-02-28
Director/Board Member 66 84-03-31
Director/Board Member 65 19-02-28
More insiders
Date Price Change Volume
24-02-26 6,008 +6.37% 3 223 700
24-02-22 5,648 -4.11% 5,166,600
24-02-21 5,890 +0.82% 2,172,400
24-02-20 5,842 +1.09% 1,860,000
24-02-19 5,779 -2.12% 1,649,000

Delayed Quote Japan Exchange, February 26, 2024 at 01:00 am EST

More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,648 JPY
Average target price
5,733 JPY
Spread / Average Target
+1.50%
Consensus
  1. Stock
  2. Equities
  3. Stock Chugai Pharmaceutical Co., Ltd - Japan Exchange
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW